(redirected from Sustiva)
Also found in: Medical.
Related to Sustiva: efavirenz, Videx, Stocrin


An antiviral drug, C14H9ClF3NO2, that is a non-nucleoside reverse transcriptase inhibitor and is used in combination with other drugs for the treatment of HIV infection.

[e(thyne) + f(luoro)- + -virenz, antiretroviral drug suffix (vir(us) + (b)enz(yl)).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n efavirenz m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
He launched Sustiva, the first once-daily anti-HIV and the 10th top-prescribed specialty drug, in 2015, and was involved in the launch of the first protease inhibitor in the United States.
During his time at BMS, He played an integral role in several virology programs in both HIV and HCV, including helping launch several medicines such as Reyataz, Sustiva and Daklinza.
Sustiva Franchise sales were down 61% to $73 million.
class="MsoNormalEfavirenz (sold under the brand name Sustiva) is an anti-HIV drug that reduces the amount of virus in the body.
Efavirenz is also called Sustiva and is part of the 3-in-l pill Atripla.
Efavirenz is a non-nucleoside transcriptase inhibitor marketed as Sustiva, or when incorporated into once-daily, fixed-dose, triple-drug therapy with tenofovir/emtricitabine, as Atripla.
Some major patent expiries are expected by the end of 2017 for Combivir, Sustiva, Tamiflu, Tenofovir, Telbivudine, and Relenza.
Relatively moderate risk: Medications used to treat viral or bacterial infections, such as flunarizine, mefloquine for malaria, efavirenz (Sustiva) for HIV and acyclovir for shingles; and cholesterol-lowering statin drugs.
Brand medications like Cipro HC, Lumigan, Sustiva, Renagel, Welchol, Trevatan and Patanol have not reached the status of household recognized names.
Treatment regimens included d4T (stavudine (Zerit)) or AZT (zidovudine (Retrovir)) with 3TC (lamivudine (Epivir)) and either efavirenz (Sustiva or Stocrin) or nevirapine (Viramune).
M2 EQUITYBITES-May 6, 2013-Bristol-Myers Squibb gets FDA approval of sNDA for SUSTIVA in HIV-1 infected pediatric patients(C)2013 M2 COMMUNICATIONS http://www.m2.com